Outpatient Surgery Magazine

Special Edition: Opioids - January 2020 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/1198986

Contents of this Issue

Navigation

Page 21 of 58

Kaye, but should not be sent in alone to battle pain. He instead says you should tap into the pain-relieving potential of these commonly used medications, which commonly serve as the basis for periopera- tive cocktails: • Ketamine has gained a resurgence as an opioid adjunct after it was shown to be an effective agonist of NMDA receptors, which play an important role in amplifying pain sensations. Research has shown ketamine's positive effect on patients with chronic pain and opioid dependency. • Gabapentin and pregabalin inhibit channels in the central nervous system that are upregulated during surgery and shut down excitatory neurotransmitters in the central nervous system. These drugs have been shown to be effective parts of opioid-sparing med- ication regimens, especially in patients who are expected to expe- rience severe post-op pain, and should be administered at least 2 hours before surgery to reach maximum effect. An important warning: Large doses of gabapentin can cause respiratory depres- sion and should be avoided. • Alpha-2 agonists possess pharmacological properties — seda- tion, hypnosis, anxiolysis, sympatholysis and analgesia — that make them useful agents of a multimodal pain regimen. Clonidine and dexmedetomidine have been shown to reduce opioid consumption after surgery. Another warning: Both drugs have a negative effect on blood flow, and can cause bradycardia and hypotension. • IV lidocaine has analgesic, antihyperalgesic and anti-inflammato- ry properties, and has been shown to help manage pain, shorten post- op stays, improve bowel function and lower PONV rates in abdominal surgery patients. • IV NSAIDs and acetaminophen decrease the release of proin- flammatory and pain-augmenting mediators at peripheral nerve sites. 2 2 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • J A N U A R Y 2 0 2 0

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - Special Edition: Opioids - January 2020 - Subscribe to Outpatient Surgery Magazine